VOYA Investment Management
ADVM

VOYA Investment Management’s Adverum Biotechnologies ADVM Stock Holding History

VOYA Investment Management’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,628
Closed -$48K – 2765
2022
Q1 		$48K Hold
3,628
– – ﹤0.01% 2596
2021
Q4 		$64K Sell
3,628
-226
-6% -$4.52K ﹤0.01% 2730
2021
Q3 		$84K Hold
3,854
– – ﹤0.01% 2772
2021
Q2 		$135K Hold
3,854
– – ﹤0.01% 2703
2021
Q1 		$380K Buy
3,854
+43
+1% +$5.16K ﹤0.01% 2175
2020
Q4 		$413K Buy
3,811
+118
+3% +$14.6K ﹤0.01% 2033
2020
Q3 		$380K Buy
3,693
+1,162
+46% +$174K ﹤0.01% 1815
2020
Q2 		$529K Sell
2,531
-607
-19% -$108K ﹤0.01% 1629
2020
Q1 		$307K Buy
3,138
+484
+18% +$56.4K ﹤0.01% 1902
2019
Q4 		$306K Buy
2,654
+469
+21% +$41.3K ﹤0.01% 2169
2019
Q3 		$119K Hold
2,185
– – ﹤0.01% 2369
2019
Q2 		$260K Buy
2,185
+164
+8% +$13.6K ﹤0.01% 2148
2019
Q1 		$106K Hold
2,021
– – ﹤0.01% 2416
2018
Q4 		$64K Hold
2,021
– – ﹤0.01% 2462
2018
Q3 		$122K Hold
2,021
– – ﹤0.01% 2468
2018
Q2 		$107K Buy
+2,021
New +$122K ﹤0.01% 2509

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

VOYA Investment Management's ADVM Position: Q2 2022 in Review

VOYA Investment Management sold out of Adverum Biotechnologies (ADVM) in Q2 2022, closing a stake of 3,628 shares — an estimated $48K sold.

VOYA Investment Management first reported a position in ADVM in Q2 2018 and held it in 16 quarters. The position peaked at $529K in Q2 2020. 77 funds tracked by Wall St. Rank hold ADVM as of Q2 2022.

  • VOYA Investment Management reported no remaining Adverum Biotechnologies position as of Q2 2022 after selling out during the quarter.
  • VOYA Investment Management sold 3,628 Adverum Biotechnologies shares in Q2 2022, an estimated $48K.
  • VOYA Investment Management first reported a position in Adverum Biotechnologies in Q2 2018 and held it in 16 quarters.
  • VOYA Investment Management's Adverum Biotechnologies position peaked at $529K in Q2 2020.
  • 77 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q2 2022.

Based on VOYA Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.